The developmental toxicity of glycolic acid was assessed in rats by orally
administering solutions of the test material in water over days 7-21 of ges
tation (the day of copulation plug detection was defined as day 1 of gestat
ion). Groups of 25 mated female Crl:CD(R)BR rats were gavaged at daily dose
levels of 0, 75, 150, 300 or 600 mg/kg. The dams were euthanized on day 22
and the offspring were weighed, sexed, and examined for external, visceral
, and skeletal alterations. Clear evidence of maternal toxicity was demonst
rated at 600 mg/kg; adverse clinical observations were statistically signif
icantly increased (wheezing/lung noise, abnormal gait/staggering, lethargy)
. In addition, maternal body weights, weight changes, and food consumption
were statistically significantly reduced at this dose level. Marginal evide
nce of maternal toxicity was demonstrated at 300 mg/kg; wheezing/lung noise
similar to that seen at 600 mg/kg was observed in 2 of 25 dams. This incre
ase approached statistical significance (p=0.0553). There was marked eviden
ce of developmental toxicity at 600 mg/kg. Mean fetal weight was statistica
lly significantly reduced while the incidences of skeletal (ribs, vertebra,
and sternebra) malformations and variations were statistically significant
ly increased. At 300 mg/kg/day, there was a slight (2 affected fetuses from
2 litters) increase in the incidence of two skeletal malformations: fused
ribs and fused vertebra. Although these increases were not statistically si
gnificant (p=0.0555), they were consistent with findings seen at 600 mg/kg/
day and thus were considered relevant. There was no other evidence of devel
opmental toxicity at 300 mg/kg/day nor was any developmental toxicity seen
at 150 or 75 mg/kg/day. Thus, the maternal and developmental no-observed-ef
fect level (NOEL) was considered 150 mg/kg.